Glioblastoma Patient Sells Home to Access Experimental Treatments Unavailable on the NHS, Highlighting Urgent Need for Research Investment
核心洞察
Jo Fuller, 51, sold her home to fund hyperthermia treatment and specialist care after standard glioblastoma (搜索) therapies failed to halt her tumour's aggressive growth.
Approximately 3,200 people are diagnosed with glioblastoma (搜索) annually in the UK, with only 4% surviving beyond five years, underscoring the disease's devastating prognosis.
Brain Tumour Research (搜索) is calling on the UK government to increase national investment in research and expand clinical trial access to prevent patients from facing such "difficult and costly decisions."
Jo Fuller, a 51-year-old dyslexia specialist from East Leake, Nottinghamshire, has sold her home to finance potentially life-extending treatments for glioblastoma (搜索) that are not routinely available on the NHS. Diagnosed nearly two years ago while on holiday in Australia, Fuller described the decision as one of the "hardest decisions" she had ever made, but said it became her "only way of accessing treatments that might give me more time."
Fuller's case has drawn renewed attention to the limited treatment options facing glioblastoma (搜索) patients in the UK and the lengths to which some must go to pursue experimental therapies abroad or through private clinics.
A Diagnosis That Changed Everything
Fuller was diagnosed with glioblastoma (搜索) in December 2024 after collapsing on Boxing Day while visiting her husband Wayne's family in Australia. The couple had been planning a two-year move to the country. "The next thing I remember was waking up on the dining room floor surrounded by paramedics. I had no idea I'd suffered a seizure and stopped breathing," Fuller recalled. She underwent brain surgery in Australia, an experience she described as "terrifying."
She returned to the UK three and a half months later to receive radiotherapy and chemotherapy. However, her first post-treatment scan revealed that the tumour had continued to grow aggressively and had spread across her brain.
Turning to Experimental Treatments
After standard treatments failed, Fuller opted to sell her property to fund continued specialist care. She has paid for hyperthermia treatment, which heats tumour tissues to between 42°C and 43°C, alongside regular consultations with an alternative oncologist, repurposed medication, and nutritional supplements. Hyperthermia is designed to make cancer cells more vulnerable to radiotherapy and chemotherapy, though its use in treating brain tumours remains largely experimental and is accessible only through clinical trials or private clinics.
Fuller is no longer undergoing hyperthermia treatment while off chemotherapy but continues to pay for three-monthly consultations, repurposed medication, and supplements, which cost hundreds of pounds each month. She has also set aside funds in case future scans show tumour growth, at which point she hopes to pursue IOZK immunotherapy treatment in Germany, a therapy not licensed in the UK.
"I never imagined I'd have to sell my home simply to keep fighting for my life," Fuller said.
The Glioblastoma (搜索) Landscape
According to Brain Tumour Research (搜索), approximately 3,200 people are diagnosed with glioblastoma (搜索) each year in the UK. Only one-third of patients survive beyond 12 months, and just 4% survive beyond five years. These stark statistics underscore the aggressive nature of the disease and the limited efficacy of current standard-of-care options.
Dr Karen Noble, director of research, policy and innovation at Brain Tumour Research (搜索), said: "Jo's story reflects the devastating reality faced by so many patients and families across the UK. With few options, some patients turn to treatments abroad, often unavailable in the UK and without any guarantee of better outcomes or improved quality of life, raising substantial funds to cover these costs."
Dr Noble added: "We urgently need Government to increase the national investment in research and expand access to innovative trials here in the UK so patients are not faced with these difficult and costly decisions."
Government Response
A Department of Health and Social Care spokesperson expressed sympathy for Fuller and all those impacted by glioblastoma (搜索) and other brain tumours. "Improving cancer research and care is a priority for this government. That's why, as part of our National Cancer Plan, we will bring the latest scientific breakthroughs into the NHS faster so that patients can benefit from earlier diagnosis and more effective treatment to live well for longer," the spokesperson said.
The spokesperson also noted that through the National Institute for Health and Care Research (搜索) (NIHR), the government is "supporting groundbreaking trials to transform outcomes for people living with brain tumours, and their families," while acknowledging that "there is more to do."
A Patient's Resolve
Fuller remains determined. "I've always told myself I'll be part of the 1% of long-term survivors," she said. "I refuse to let glioblastoma (搜索) decide my future, but there desperately needs to be more research so families like mine have better treatment options and more hope."
She added: "No one should have to sell their home to access treatments that might prolong their life, and no family should feel as though there are no more options simply because research hasn't progressed quickly enough. I hope that one day, people diagnosed with this disease will have far more hope than I was given, and that's why I'll keep telling my story."